CatalYm GmbH
Developing innovative immunotherapies to transform cancer patients’ lives by engaging their own immune systems.
58 employees · est. 2016 · Germany
Thunder Biotech
MOTO-CAR®s: Innovative macrophage technology designed to provide effective treatment for patients with solid tumors.
15 employees · est. 2016 · Provo, United States
CatalYm GmbH is the larger of the two.
2 signals in the last 90 days
Side-by-Side Comparison
| Metric | CatalYm GmbH | Thunder Biotech |
|---|---|---|
| Founded | ||
| Founded | 2016 | 2016 |
| Headquarters | ||
| Headquarters | Germany | Provo, United States |
| Employees | ||
| Employees | 58 larger | 15 |
| Industry | ||
| Industry | Biotechnology, Health Care, Health and Wellness | Biotechnology, Pharmaceutical |
| Funding Stage | ||
| Funding Stage | Series D | Debt Financing |
| Total Funding | ||
| Total Funding | $250.00M | $24.51M |
| Funding Rounds | ||
| Funding Rounds | 4 | 6 |
| Services | ||
| Services | Development of immunotherapies targeting GDF-15, Conducting clinical trials for cancer treatment, Advancing drug candidates for cachexia associated with cancer | Not tracked yet |
| Target Customers | ||
| Target Customers | Oncologists, Cancer Centers, Pharmaceutical Companies, Healthcare Providers | Not tracked yet |
| Taxonomy | ||
| Taxonomy | Immunotherapy, Cancer Treatment, Oncology, Antibody Development, Tumor Microenvironment, GDF-15 Targeting, Solid Tumors, Neutralizing Antibodies, Immune System Engagement, Placental Factor Overproduction, CT-002 Program, Clinical Proof-of-Concept, Therapeutic Innovation, Tumor-Specific Treatment | Immune-oncology, MOTO-CAR Technology, Solid Tumors, Cancer Treatment, Genetic Engineering, CAR Macrophages, Tumor Associated Macrophages, T Cell Response, Tumor Cell Destruction, Immunotherapy, Tumor Recurrence Prevention |
| Website | ||
| Website | catalym.com | thunderbiotech.com |
About CatalYm GmbH
CatalYm GmbH, founded in 2016, is a Germany-based company deeply embedded in the Biotechnology and Health Care sectors. The company's mission—"Developing innovative immunotherapies to transform cancer patients’ lives by engaging their own immune systems"—captures its commitment to advancing medical...
About Thunder Biotech
Thunder Biotech is a biotechnology and pharmaceutical company based in the United States, founded in 2016. The company's flagship product, MOTO-CAR®, is an innovative macrophage technology designed to provide effective treatment for patients with solid tumors. Thunder Biotech is focused on developin...
We will tell you when either one moves
BounceWatch watches CatalYm GmbH and Thunder Biotech for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.
Funding, hiring, leadership and stack changes at CatalYm GmbH and Thunder Biotech — by email.
Frequently Asked Questions
Compare CatalYm GmbH with someone else
Start typing a company name or domain.
Related Comparisons
Compiled from the BounceWatch company index. We last looked at CatalYm GmbH on 28 May 2026, and Thunder Biotech on 12 Sep 2024. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.